
OPPORTUNITY VALUATION
Red Team Associates assesses gaps in the market, giving clients a snapshot of the opportunity. We develop a differentiated value proposition and can help assemble a forecast of future market potential.
Below are a few examples of life science companies and products we have valuated the opportunity.

Situation
-
Developing Phase II integrin agonist (Luminate®) with multiple ophthalmic indications potential
-
DME
-
Wet AMD
-
Dry AMD
-
Retinitis pigmentosa
-
Activities
-
Multiple engagements
-
Retinal surgeons
-
Payers
-
Patients
-
-
Developed forecast indication market potential
Impact
-
Helped prioritize indications
-
Provided guidance on structure of Phase III trial
-
Helped support securing of $20MM financing

Situation
-
Developing intranasal version of epinephrine delivery device to replace EpiPen
-
Privately backed, brought in by Chairman
Activities
-
Assessed the value of technology in US and EU
-
Physicians – Allergists, Pediatricians, ER
-
Payers
-
Patients
-
Caregivers
-
School nurses
-
Impact
-
Developed initial forecast market potential
-
Helped support securing of $20MM financing
-
Acted as Chief Marketing Officer

Situation
-
Exact Sciences was developing Cologuard, an at-home colon cancer screening test
-
Company needed to finalize product design
-
Needed guidance on how to address GI concerns
Activities
-
Assessed the Cologuard product
-
Physicians – Gastroenterologists
-
Payers
-
Male and female patients
-
-
Developed initial go-to-market strategy
Impact
-
Helped in the design of Cologuard
-
Product
-
Delivery
-
Sensitivity/Specificity
-
-
Company went IPO; now market cap >$12B